Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Farah Raheem"'
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 22, p 16198 (2023)
Endocrine therapy is the main treatment for hormone receptor-positive (HR+) breast cancer. However, advanced tumors develop resistance to endocrine therapy, rendering it ineffective as the disease progresses. There are several molecular mechanisms of
Externí odkaz:
https://doaj.org/article/36af0333fe38426aa82142cea76ea66f
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 950 (2023)
Objective: This study is a comprehensive review of the clinical pharmacology, pharmacokinetics, efficacy, safety, and clinical applicability of amivantamab-vmjw for metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (
Externí odkaz:
https://doaj.org/article/e0ad725d81794bc4a3d167d04f151a29
Publikováno v:
Cancers, Vol 14, Iss 17, p 4332 (2022)
Poly-adenosine diphosphate ribose polymerase (PARP) inhibitors (PARPi) are approved for BRCA1/2 carriers with HER2-negative breast cancer in the adjuvant setting with a high risk of recurrence as well as the metastatic setting. However, the indicatio
Externí odkaz:
https://doaj.org/article/1b9299fa8a08491ba127963f7557facd
Publikováno v:
Pharmacy, Vol 8, Iss 1, p 32 (2020)
Recent advancements in molecular testing, the availability of cost-effective technology, and novel approaches to clinical trial design have facilitated the implementation of tumor genome sequencing into standard of care oncology practices. Current mo
Externí odkaz:
https://doaj.org/article/6584e95d415b46ceb3fa1b3e51a5ba5c
Autor:
Julianne O. Darling, Farah Raheem, Katelyn C. Carter, Elizabeth Ledbetter, Jennifer F. Lowe, Christopher Lowe
Publikováno v:
Pharmacy, Vol 8, Iss 1, p 46 (2020)
Oral chemotherapy represents a major patient-centric advancement in therapy convenience. However, ownership of safe and correct administration of these agents requires significant patient education. To address this challenge, an in-person pharmacist-
Externí odkaz:
https://doaj.org/article/dda3bedaf08a4ac3933c2c7338ba9c70
Autor:
Kaylee Clark, Jamie L. Carroll, Alvaro Moreno-Aspitia, Brenda Ernst, Farah Raheem, Ashley Heil, Beth Boyer, Kristin Mara, Matthew P. Goetz, Roberto A. Leon-Ferre, Karthik V. Giridhar, Jodi Taraba
Publikováno v:
Cancer Research. 83:P4-07
Background: SG was approved in 2020 for the treatment of metastatic triple negative breast cancer (TNBC). The most common grade 3/4 adverse event in the ASCENT trial was neutropenia (51.2%) with a 6% incidence of febrile neutropenia. 1 Package insert
Autor:
Donald C. Moore, Matthew R. Peery, Katherine A. Tobon, Farah Raheem, Grace S. Hwang, Lin Alhennawi, Mitchell E. Hughes
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1848-1858
Diffuse large B-cell lymphoma (DLBCL) is the most common form of aggressive non-Hodgkin lymphoma. Approximately 40% of patients with DLBCL will experience disease relapse or will be refractory to first line chemoimmunotherapy, necessitating second-li
Autor:
Farah Raheem, Vishal Shah
Publikováno v:
Breast Cancer Updates
Breast Cancer Updates ISBN: 9781803559308
Breast Cancer Updates ISBN: 9781803559308
Antibody drug conjugates (ADCs) continue to change the treatment paradigm of breast cancer and recent regulatory approvals of next generation ADCs are shifting how breast cancer is classified and treated. ADCs combine precision targeting with traditi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea9e9dae78d762ca13eeb111214b1e0
https://mts.intechopen.com/articles/show/title/antibody-drug-conjugates
https://mts.intechopen.com/articles/show/title/antibody-drug-conjugates
Publikováno v:
Annals of Pharmacotherapy. 56:1258-1266
Objective: To review the new indication of cyclin-dependent kinase (CDK4/6) inhibitor abemaciclib for the adjuvant treatment of hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2−), axillary lymph node (LN) pos
Publikováno v:
Pharmacy
Volume 8
Issue 1
Pharmacy: Journal of Pharmacy Education and Practice
Pharmacy, Vol 8, Iss 1, p 32 (2020)
Volume 8
Issue 1
Pharmacy: Journal of Pharmacy Education and Practice
Pharmacy, Vol 8, Iss 1, p 32 (2020)
Recent advancements in molecular testing, the availability of cost-effective technology, and novel approaches to clinical trial design have facilitated the implementation of tumor genome sequencing into standard of care oncology practices. Current mo